查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1668191

組織工程市場 - 全球產業規模、佔有率、趨勢、機會和預測，按材料類型、應用、最終用戶、地區和競爭情況細分，2020-2030 年預測

Tissue Engineering Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Material Type, By Application, By End User By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球組織工程市場價值為 135 億美元，預計將經歷顯著成長，到 2030 年的年複合成長率(CAGR) 為 9.20%。該領域涉及應用生物學、化學和工程學原理來創建用於醫療應用的功能組織和器官。市場的成長是由器官移植需求的不斷成長、捐贈器官的短缺以及對先進治療方案的需求所推動的。

市場概況
預測期 2026-2030
2024 年市場規模 135 億美元
2030 年市場規模 229.4 億美元
2025-2030 年複合年成長率 9.20%
成長最快的領域 生物衍生材料
最大的市場 北美洲

組織工程市場擴張的關鍵促進因素是心血管疾病、糖尿病和骨科疾病等慢性疾病和傷害的發生率不斷上升。組織工程為開發針對特定患者的治療方法提供了創新的解決方案，包括工程器官、組織和植入物，以解決這些關鍵的健康問題。此外，全球人口老化進一步促進了市場的成長，因為老年人經常需要基於組織的療法來提高他們的生活品質。

生物技術、生物材料和 3D 列印技術的進步正在推動組織工程邁向新的水平。公司和研究人員擴大利用這些創新來創造與自然器官緊密模仿的複雜功能組織，從而提高移植成功率並降低排斥風險。幹細胞研究、CRISPR-Cas9 等基因編輯技術以及生物相容性材料的整合為組織工程中的個人化醫療方法鋪平了道路。

全球組織工程市場具有廣泛的應用範圍，包括皮膚移植、骨骼和軟骨修復、心臟瓣膜，甚至腎臟和肝臟等整個器官。這些應用涵蓋了從骨科到皮膚科和心臟病學等各個醫療領域，凸顯了市場的多功能性和成長潛力。

主要市場促進因素

慢性病和傷害盛行率上升

主要市場挑戰

複雜的監理框架

主要市場趨勢

多種應用

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第4章：全球組織工程市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依材料類型（合成材料、生物衍生材料、其他）
    • 依應用分類（骨科、肌肉骨骼及脊椎、神經內科、心臟科、皮膚及體皮、其他）
    • 按最終用戶（醫院、癌症研究中心、學術和研究機構等）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖
    • 依材料類型
    • 按應用
    • 按最終用戶
    • 按地區

第5章：亞太組織工程市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依材料類型
    • 按應用
    • 按最終用戶
    • 按國家
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 澳洲
    • 日本
    • 韓國

第6章：歐洲組織工程市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 德國
    • 西班牙
    • 義大利
    • 英國

第 7 章：北美組織工程市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 墨西哥
    • 加拿大

第 8 章：南美洲組織工程市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 阿根廷
    • 哥倫比亞

第 9 章：中東和非洲組織工程市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 10 章：市場動態

  • 驅動程式
  • 挑戰

第 11 章：市場趨勢與發展

  • 最新動態
  • 產品發布
  • 合併與收購

第 12 章：全球組織工程市場：SWOT 分析

第 13 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 14 章：競爭格局

  • Zimmer Biomet Holdings Inc.
  • Stryker Corporation Holdings
  • 3D BioFibR Inc.
  • Integra LifeSciences Corporation
  • CollPlant Biotechnologies Ltd.
  • AbbVie (Allergan Aesthetics)
  • Becton, Dickinson and Company
  • Athersys, Inc.
  • BioTissue
  • Japan Tissue Engineering Co., Ltd

第 15 章：策略建議

第16章 關於出版商,免責事項

簡介目錄
Product Code: 17591

The Global Tissue Engineering Market was valued at USD 13.50 billion in 2024 and is projected to experience significant growth, with a compound annual growth rate (CAGR) of 9.20% through 2030. Tissue engineering has become a dynamic and rapidly evolving segment within regenerative medicine and biotechnology. This field involves applying principles from biology, chemistry, and engineering to create functional tissues and organs for medical applications. The market's growth is driven by the increasing demand for organ transplants, a shortage of donor organs, and the need for advanced therapeutic solutions.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 13.50 Billion
Market Size 2030USD 22.94 Billion
CAGR 2025-20309.20%
Fastest Growing SegmentBiologically Derived Materials
Largest MarketNorth America

A key driver behind the expansion of the tissue engineering market is the rising incidence of chronic diseases and injuries, such as cardiovascular diseases, diabetes, and orthopedic conditions. Tissue engineering offers innovative solutions for the development of patient-specific treatments, including engineered organs, tissues, and implants, addressing these critical health issues. Additionally, the aging global population further contributes to the market's growth, as elderly individuals frequently require tissue-based therapies to enhance their quality of life.

Technological advancements in biotechnology, biomaterials, and 3D printing are propelling tissue engineering to new levels. Companies and researchers are increasingly leveraging these innovations to create complex, functional tissues that closely mimic natural organs, improving transplant success rates and reducing rejection risks. The integration of stem cell research, gene editing techniques such as CRISPR-Cas9, and biocompatible materials has paved the way for personalized medicine approaches within tissue engineering.

The global tissue engineering market is characterized by a broad range of applications, including skin grafts, bone and cartilage repair, heart valves, and even whole organs such as kidneys and livers. These applications span various medical fields, from orthopedics to dermatology and cardiology, highlighting the market's versatility and growth potential.

Key Market Drivers

Rising Prevalence of Chronic Diseases and Injuries

The tissue engineering market is experiencing rapid growth, largely driven by the increasing global prevalence of chronic diseases and injuries. Cardiovascular diseases, which impact the heart and blood vessels, account for 18 million deaths annually worldwide, with cancer causing 9 million deaths and chronic respiratory diseases contributing to 4 million fatalities. Diabetes is responsible for 2 million deaths each year. These figures emphasize the substantial health burden posed by non-communicable diseases, underscoring the critical need for innovative healthcare solutions. As the demand for regenerative treatments grows, tissue engineering is emerging as a crucial component of modern medicine.

Chronic conditions such as cardiovascular diseases, diabetes, orthopedic disorders, and trauma-related injuries necessitate advanced tissue regeneration and organ repair solutions. Tissue engineering offers effective regenerative solutions to repair or replace damaged tissues resulting from these conditions. For example, tissue-engineered blood vessels, heart valves, and cardiac patches are in high demand due to the increasing incidence of cardiovascular complications. Similarly, tissue-engineered skin grafts and cell-based therapies are helping diabetic patients heal chronic wounds and foot ulcers.

As healthcare systems shift focus toward treating chronic illnesses, bioprinted tissues, scaffold-based regenerative treatments, and stem cell therapies are becoming key solutions, further driving the market's expansion.

Key Market Challenges

Complex Regulatory Frameworks

The complex regulatory landscape is a significant challenge to the growth and development of the Global Tissue Engineering Market. While regulations are necessary to ensure the safety and efficacy of medical products, the evolving nature of tissue engineering presents unique obstacles for both industry stakeholders and regulatory bodies. A major challenge is the classification and oversight of tissue-engineered products, which may fall under various regulatory categories, including medical devices, biologics, or combination products, depending on their intended use and composition. This ambiguity often requires engagement with multiple regulatory agencies, each with its own set of requirements, making the process time-consuming and cumbersome.

The lengthy and stringent approval processes for tissue-engineered products are another major hurdle. Regulatory agencies, such as the FDA (Food and Drug Administration) in the United States and the EMA (European Medicines Agency) in Europe, require extensive preclinical and clinical data to demonstrate the safety and efficacy of these products. While this is crucial for patient safety, it can lead to delays in market entry and increased development costs. Additionally, the rapid pace of advancements in tissue engineering often outstrips the ability of regulators to adapt their frameworks, creating uncertainty for companies engaged in R&D.

Key Market Trends

Diverse Range of Applications

The Global Tissue Engineering Market is experiencing significant growth, primarily due to its broad range of applications across various medical fields. Initially focused on repairing and replacing damaged tissues, tissue engineering has expanded to address a wide array of healthcare challenges, driving market growth.

One notable application is in orthopedics and musculoskeletal medicine. Tissue-engineered solutions are helping patients with bone fractures, cartilage defects, and joint injuries regenerate these essential structures. Advanced biomaterials and scaffold designs are enabling the creation of custom-made bone grafts and cartilage implants that integrate seamlessly with patients' tissues, improving mobility and reducing pain.

In dermatology, tissue-engineered skin substitutes are offering effective solutions for chronic wounds, burns, and skin defects. These skin grafts promote tissue regeneration, enhance healing, and reduce scarring. In cardiology, tissue-engineered heart valves and cardiac patches hold significant potential, offering alternatives to traditional treatments and improving cardiac function.

Beyond these areas, tissue engineering is also making strides in ophthalmology, neurology, and urology. For instance, tissue-engineered corneas are being developed to treat vision impairments, while neural tissue engineering is targeting spinal cord injuries and neurodegenerative disorders. Additionally, tissue-engineered bladders and urethras are being explored to address urinary tract conditions.

Key Market Players

  • Zimmer Biomet Holdings Inc.
  • Stryker Corporation
  • 3D BioFibR Inc.
  • Integra LifeSciences Corporation
  • CollPlant Biotechnologies Ltd.
  • AbbVie (Allergan Aesthetics)
  • Becton, Dickinson and Company
  • Athersys, Inc.
  • BioTissue
  • Japan Tissue Engineering Co., Ltd.

Report Scope

This report segments the Global Tissue Engineering Market based on the following categories:

By Material Type:

  • Synthetic Materials
  • Biologically Derived Materials
  • Others

By Application:

  • Orthopedics
  • Musculoskeletal & Spine
  • Neurology
  • Cardiology
  • Skin & Integumentary
  • Others

By End-User:

  • Hospitals
  • Cancer Research Centers
  • Academic and Research Institutes
  • Others

By Region:

  • North America (United States, Canada, Mexico)
  • Europe (France, United Kingdom, Italy, Germany, Spain)
  • Asia-Pacific (China, India, Japan, Australia, South Korea)
  • South America (Brazil, Argentina, Colombia)
  • Middle East & Africa (South Africa, Saudi Arabia, UAE)

Competitive Landscape and Company Profiles:

The report includes detailed analyses of the major companies operating in the Global Tissue Engineering Market.

Available Customizations:

TechSci Research offers the ability to customize the report according to a company's specific needs, including profiling additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Tissue Engineering Market Outlook

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share & Forecast
    • 4.2.1. By Material Type (Synthetic Materials, Biologically Derived Materials, Others)
    • 4.2.2. By Application (Orthopedics, Musculoskeletal & Spine, Neurology, Cardiology, Skin & Integumentary, Others)
    • 4.2.3. By End User (Hospitals, Cancer Research Centers, Academic and Research Institutes, Others)
    • 4.2.4. By Region
    • 4.2.5. By Company (2024)
  • 4.3. Market Map
    • 4.3.1. By Material Type
    • 4.3.2. By Application
    • 4.3.3. By End User
    • 4.3.4. By Region

5. Asia Pacific Tissue Engineering Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Material Type
    • 5.2.2. By Application
    • 5.2.3. By End User
    • 5.2.4. By Country
  • 5.3. Asia Pacific: Country Analysis
    • 5.3.1. China Tissue Engineering Market Outlook
      • 5.3.1.1. Market Size & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share & Forecast
        • 5.3.1.2.1. By Material Type
        • 5.3.1.2.2. By Application
        • 5.3.1.2.3. By End User
    • 5.3.2. India Tissue Engineering Market Outlook
      • 5.3.2.1. Market Size & Forecast
        • 5.3.2.1.1. By Value
      • 5.3.2.2. Market Share & Forecast
        • 5.3.2.2.1. By Material Type
        • 5.3.2.2.2. By Application
        • 5.3.2.2.3. By End User
    • 5.3.3. Australia Tissue Engineering Market Outlook
      • 5.3.3.1. Market Size & Forecast
        • 5.3.3.1.1. By Value
      • 5.3.3.2. Market Share & Forecast
        • 5.3.3.2.1. By Material Type
        • 5.3.3.2.2. By Application
        • 5.3.3.2.3. By End User
    • 5.3.4. Japan Tissue Engineering Market Outlook
      • 5.3.4.1. Market Size & Forecast
        • 5.3.4.1.1. By Value
      • 5.3.4.2. Market Share & Forecast
        • 5.3.4.2.1. By Material Type
        • 5.3.4.2.2. By Application
        • 5.3.4.2.3. By End User
    • 5.3.5. South Korea Tissue Engineering Market Outlook
      • 5.3.5.1. Market Size & Forecast
        • 5.3.5.1.1. By Value
      • 5.3.5.2. Market Share & Forecast
        • 5.3.5.2.1. By Material Type
        • 5.3.5.2.2. By Application
        • 5.3.5.2.3. By End User

6. Europe Tissue Engineering Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Material Type
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. Europe: Country Analysis
    • 6.3.1. France Tissue Engineering Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Material Type
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Germany Tissue Engineering Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Material Type
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Spain Tissue Engineering Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Material Type
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User
    • 6.3.4. Italy Tissue Engineering Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Material Type
        • 6.3.4.2.2. By Application
        • 6.3.4.2.3. By End User
    • 6.3.5. United Kingdom Tissue Engineering Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Material Type
        • 6.3.5.2.2. By Application
        • 6.3.5.2.3. By End User

7. North America Tissue Engineering Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Material Type
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Tissue Engineering Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Material Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. Mexico Tissue Engineering Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Material Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. Canada Tissue Engineering Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Material Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User

8. South America Tissue Engineering Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Material Type
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. South America: Country Analysis
    • 8.3.1. Brazil Tissue Engineering Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Material Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. Argentina Tissue Engineering Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Material Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. Colombia Tissue Engineering Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Material Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User

9. Middle East and Africa Tissue Engineering Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Material Type
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. MEA: Country Analysis
    • 9.3.1. South Africa Tissue Engineering Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Material Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. Saudi Arabia Tissue Engineering Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Material Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. UAE Tissue Engineering Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Material Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. Market Dynamics

  • 10.1. Drivers
  • 10.2. Challenges

11. Market Trends & Developments

  • 11.1. Recent Developments
  • 11.2. Product Launches
  • 11.3. Mergers & Acquisitions

12. Global Tissue Engineering Market: SWOT Analysis

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Product

14. Competitive Landscape

  • 14.1. Zimmer Biomet Holdings Inc.
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Financials (In case of listed)
    • 14.1.5. Recent Developments
    • 14.1.6. SWOT Analysis
  • 14.2. Stryker Corporation Holdings
  • 14.3. 3D BioFibR Inc.
  • 14.4. Integra LifeSciences Corporation
  • 14.5. CollPlant Biotechnologies Ltd.
  • 14.6. AbbVie (Allergan Aesthetics)
  • 14.7. Becton, Dickinson and Company
  • 14.8. Athersys, Inc.
  • 14.9. BioTissue
  • 14.10. Japan Tissue Engineering Co., Ltd

15. Strategic Recommendations

16. About Us & Disclaimer